Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2,325Revenue (TTM) $M521Net Margin (%)13.0Altman Z-Score8.0
Enterprise Value $M2,146EPS (TTM) $1.1Operating Margin %17.7Piotroski F-Score8
P/E(ttm)35.6Beneish M-Score-2.8Pre-tax Margin (%)18.8Higher ROA y-yY
Price/Book2.110-y EBITDA Growth Rate %4.5Quick Ratio3.8Cash flow > EarningsY
Price/Sales4.65-y EBITDA Growth Rate %9.0Current Ratio4.7Lower Leverage y-yY
Price/Free Cash Flow29.0y-y EBITDA Growth Rate %7.2ROA % (ttm)7.4Higher Current Ratio y-yY
Dividend Yield %0.9PEG4.0ROE % (ttm)9.6Less Shares Outstanding y-yY
Payout Ratio %33.0Shares Outstanding M38.0ROIC % (ttm)11.3Gross Margin Increase y-yY

Gurus Latest Trades with TR

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

TR is held by these investors:



TR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GORDON ELLEN RPresident, 10% Owner 2016-12-06Sell53,355$38.45-2.86view
GORDON ELLEN RPresident, 10% Owner 2016-12-06Buy53,355$38.45-2.86view
LEWIS BRENT LANA JANEDirector 2014-07-31Buy15,914$25.3747.22view
LEWIS BRENT LANA JANEDirector 2013-05-07Sell16,320$28.2732.12view
LEWIS BRENT LANA JANEDirector 2012-03-07Buy2,502$20.1385.54view
WEINER LEIGH R10% Owner 2008-01-23Sell65,239$19.3992.63view
WEINER LEIGH R10% Owner 2006-03-29Sell167,990$21.573.72view
Seibert Barre ADirector 2006-01-06Buy692$20.6381.05view
Seibert Barre ADirector 2005-05-09Buy692$21.9570.16view
LEWIS BRENT LANA JANEDirector 2005-03-22Buy3,668$21.2575.76view

Press Releases about TR :

Quarterly/Annual Reports about TR:

News about TR:

Articles On GuruFocus.com
Trillium Therapeutics Announces Presentation on TTI-621 Immune Checkpoint Inhibitor Targeting CD47 a Jun 07 2016 
Trillium Announces Voting Results From the Annual and Special Meeting of Shareholders May 31 2016 
Trillium Therapeutics Announces Presentation on TTI-621 Immune Checkpoint Inhibitor Targeting CD47 a May 18 2016 
Trillium Reports First Quarter 2016 Financial Results May 13 2016 
Trillium to Provide Update on CD47 Program at the 2016 American Association for Cancer Research Annu Apr 14 2016 
Trillium to Present at the 2016 Annual Needham Health Care Conference Apr 12 2016 
Trillium Announces a $3.4 Million Government Co-Funded Translational Research Program Mar 10 2016 
Trillium Reports 2015 Financial and Operating Results Mar 09 2016 
Trillium to Present at the Cowen and Company 36th Annual Health Care Conference Mar 08 2016 
Trillium Therapeutics Doses First Patient With TTI-621, a Novel Immune Checkpoint Inhibitor Targetin Feb 03 2016 

More From Other Websites
Tootsie Roll posts 1Q profit Apr 25 2017
Tootsie Roll Industries, Inc. breached its 50 day moving average in a Bullish Manner : TR-US : April... Apr 10 2017
ETFs with exposure to Tootsie Roll Industries, Inc. : April 7, 2017 Apr 07 2017
Tootsie Roll Industries, Inc. : TR-US: Dividend Analysis : March 07th, 2017 (record date) : By the... Apr 03 2017
3 Dividend Champions We Refuse to Buy Mar 27 2017
Tootsie Roll Industries, Inc. breached its 50 day moving average in a Bearish Manner : TR-US : March... Mar 27 2017
Tootsie Roll Industries, Inc. :TR-US: Earnings Analysis: Q4, 2016 By the Numbers : March 2, 2017 Mar 02 2017
Go Long Tootsie Roll, Short Twinkies Mar 01 2017
Tootsie Roll Industries, Inc. : TR-US: Dividend Analysis : December 19th, 2016 (record date) : By... Feb 06 2017
Tootsie Roll Industries, Inc. – Value Analysis (NYSE:TR) : January 11, 2017 Jan 11 2017
Tootsie Roll Industries, Inc. breached its 50 day moving average in a Bearish Manner : TR-US :... Jan 10 2017
ETFs with exposure to Tootsie Roll Industries, Inc. : January 9, 2017 Jan 09 2017
How Blockchain Could Help Strengthen Developing Nations Dec 27 2016
ETFs with exposure to Tootsie Roll Industries, Inc. : December 21, 2016 Dec 21 2016
Insider Buying Stays Red-Hot as Trump Rally Rolls On: Wendy’s, Medicines Company, Transdigm and... Dec 11 2016
Tootsie Roll Industries, Inc. (TR): Are Hedge Funds Right About This Stock? Dec 08 2016
Tootsie Roll Industries, Inc. :TR-US: Earnings Analysis: Q3, 2016 By the Numbers : November 16, 2016 Nov 16 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)